Filing Details

Accession Number:
0001181431-13-003638
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-17 16:10:33
Reporting Period:
2013-01-15
Filing Date:
2013-01-17
Accepted Time:
2013-01-17 16:10:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1135906 Zalicus Inc. ZLCS Pharmaceutical Preparations (2834) 043514457
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1250661 Mark Corrigan C/O Zalicus Inc.
245 First Street, 3Rd Floor
Cambridge MA 02142
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-01-15 112,850 $0.77 844,090 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported by this form were to satisfy statutory tax withholding requirements upon vesting of restricted stock units.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.74. The reporting person untertakes to provide to Zalicus Inc., any security holder of Zalicus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2 to this Form 4.